A new KFF analysis finds donor government support for global family planning efforts totaled US$1.5 billion in 2019, matching the previous year’s record level and well above the US$1.1 billion in 2012 since the London Summit on Family Planning that created an international goal of increasing family planning services. The…
- view as grid
- view as list
In this Viewpoint for the Journal of the American Medical Association (JAMA), KFF’s Tricia Neuman and co-author Richard G. Frank of Harvard Medical School explain that the looming 2024 insolvency of the Medicare Hospital Insurance Trust Fund cannot be ignored for long.
Additional Data Available Through Online Vaccine Monitor Dashboard As vaccination efforts ramp up across the country, the KFF COVID-19 Vaccine Monitor examines where the public is getting its relevant information. Large shares of the public report that they are getting at least a fair amount of vaccine information from television…
A new KFF analysis finds that across 46 PEPFAR countries and among six different indicators of progress, the majority (40) has met at least one target. The analysis is part of a dashboard that provides a detailed look at progress being made to address the HIV/AIDS epidemic in countries where PEPFAR operates.
At This Early Stage of the COVID-19 Vaccine Roll-Out, Most Older Adults Have Not Yet Been Vaccinated As Supply Remains Limited
With the COVID-19 vaccination rollout still in its early stages, a KFF analysis finds that most older adults have not yet been vaccinated against the potentially deadly virus, as vaccine supplies remain limited and most states have only recently begun to make people 65 and older eligible. Since January 12,…
A Status Report on Prescription Drug Policies and Proposals at the Start of the Biden Administration
This brief provides a status update on prescription drug final rules advanced by the Trump Administration in its final months related to Medicare, importation, and 340B pricing for insulin and epinephrine, and an overview of key drug pricing proposals related to Medicare and prescription drug prices generally that were voted on but not enacted in the previous Congress that may return to the forefront of health policy discussions in the coming years.
This analysis examines the different approaches states are taking to manage the limited initial supply of COVID-19 vaccines and balance the desire to vaccinate those at greatest risk first with the need to ensure a fast and effective statewide vaccination effort. It includes a state data table.
A new KFF analysis examines the different approaches states are taking to manage the limited initial supply of COVID-19 vaccines and balance the desire to vaccinate those at greatest risk first with the need to ensure a fast and effective statewide vaccination effort. Based on a review of state vaccination…
This list of Frequently Asked Questions (FAQs) about Medicare Open Enrollment covers a range of topics related to Medicare enrollment, Medicare Advantage, Part D, Medigap, employer/retiree coverage, Medicaid and other low-income assistance, Medicare and the Marketplaces, and more.
Encuentre respuestas a las preguntas más frecuentes sobre la inscripción al Medicare, Medicare Advantage, Parte D, Medigap y más.